Immunotherapy for Metastatic Kidney Cancer Shows Increased Survival
2 Visningar
• 07/10/23
0
0
Bädda in
administrator
Prenumeranter
The immune checkpoint inhibitor Opdivo (nivolumab) has been shown to increase survival for patients with metastatic clear cell kidney cancer (also called renal cell carcinoma, or RCC).
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna